CXCL12 and cancer: Together, these results underscore how different cancer cells respond to the CXCL12/HMGB1 heterocomplex enhancing directional cell migration and invasion, which depends on the balance between maintaining HMGB1 in its reduced form and promptly removing CXCL12 from the microenvironment.